Name (Synonyms) | Correlation | |
---|---|---|
drug2629 | Simplified Geriatric Evaluation Wiki | 0.71 |
drug3187 | autologous adipose-derived stem cells Wiki | 0.71 |
Name (Synonyms) | Correlation | |
---|---|---|
D000073496 | Frailty NIH | 0.29 |
D045169 | Severe Acute Respiratory Syndrome NIH | 0.03 |
D018352 | Coronavirus Infections NIH | 0.03 |
Name (Synonyms) | Correlation |
---|
There are 2 clinical trials
The ANRS EP66 SEPTAVIH Study aims to screen feasibility of evaluating frailty in people living with HIV aged 70 or older, to estimate its prevalence, to analyse associated risk factors and to evaluate the impact of frailty on pejorative events. SEPTAVIH is a French, multicentre, prospective, observational study which will include 500 HIV-infected participants
Description: Proportion of patients classified as frail according to Fried at Baseline
Measure: Proportion of frail patients Time: 12 monthsSARS-CoV-2, the virus that causes coronavirus disease 2019 (COVID-19), has negatively impacted global health and requires more research to develop better tests and to improve disease treatment. The purpose of this research is to aid in the testing effort by collecting samples from people who have been diagnosed with COVID-19 or are suspected of having COVID-19. Samples you provide will be used investigationally by INanoBio to develop a test to determine when antibodies against various SARS-CoV-2 proteins are detectable. Up to approximately 80 subjects of all ages with either a suspected or lab-confirmed diagnosis of COVID-19 will take part in this research.
Description: Detection versus No Detection of the virus and indicate which viral protein antigens are most useful for serological testing.
Measure: Detection Test of COVID-19 Time: through study completion, an average of 1 year